CORT Q1 2022 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$94M+17.9% YoY

Gross Profit

$92M98.7% margin

Operating Income

$27M28.6% margin

Net Income

$23M24.3% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

-5.2%

Cash Flow

Operating Cash Flow

$35M

Free Cash Flow

$35M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$468M

Total Liabilities

$60M

Stockholders' Equity

$408M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$79M	+17.9%
Gross Profit	$92M	$78M	+18.3%
Operating Income	$27M	$20M	+36.3%
Net Income	$23M	$23M	-2.8%